241 related articles for article (PubMed ID: 26101460)
1. Harnessing the Therapeutic Potential of Th17 Cells.
Bystrom J; Taher TE; Muhyaddin MS; Clanchy FI; Mangat P; Jawad AS; Williams RO; Mageed RA
Mediators Inflamm; 2015; 2015():205156. PubMed ID: 26101460
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
4. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.
Paulissen SM; van Hamburg JP; Dankers W; Lubberts E
Cytokine; 2015 Jul; 74(1):43-53. PubMed ID: 25828206
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.
Søndergaard JN; Laursen JM; Rosholm LB; Brix S
Int Immunol; 2014 Dec; 26(12):705-16. PubMed ID: 25223368
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.
Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG
Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266
[TBL] [Abstract][Full Text] [Related]
7. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells in renal inflammation and autoimmunity.
Dolff S; Witzke O; Wilde B
Autoimmun Rev; 2019 Feb; 18(2):129-136. PubMed ID: 30572135
[TBL] [Abstract][Full Text] [Related]
9. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
10. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
[TBL] [Abstract][Full Text] [Related]
11. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Patel DD; Kuchroo VK
Immunity; 2015 Dec; 43(6):1040-51. PubMed ID: 26682981
[TBL] [Abstract][Full Text] [Related]
12. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
[TBL] [Abstract][Full Text] [Related]
13. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
14. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
15. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
Du R; Zhao H; Yan F; Li H
J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
[TBL] [Abstract][Full Text] [Related]
16. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.
Eljaafari A; Tartelin ML; Aissaoui H; Chevrel G; Osta B; Lavocat F; Miossec P
Arthritis Rheum; 2012 Jul; 64(7):2147-57. PubMed ID: 22275154
[TBL] [Abstract][Full Text] [Related]
18. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin.
Cosmi L; Liotta F; Maggi E; Romagnani S; Annunziato F
Int Arch Allergy Immunol; 2014; 164(3):171-7. PubMed ID: 25033972
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting RORγt/Th17 axis for autoimmune disorders.
Isono F; Fujita-Sato S; Ito S
Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
